New Results
Exploratory analyses suggest less cognitive decline on nilvadipine treatment in very mild Alzheimer’s disease subjects
View ORCID ProfileLaila Abdullah, Fiona Crawford, Langlois Heather, Hendrix Suzanne, Sean Kennelly, Brian Lawlor, Mullan Michael
doi: https://doi.org/10.1101/345652
Laila Abdullah
1Archer Pharmaceuticals, Sarasota, FL, USA
2Roskamp Institute, Sarasota, FL, USA
Fiona Crawford
1Archer Pharmaceuticals, Sarasota, FL, USA
2Roskamp Institute, Sarasota, FL, USA
Langlois Heather
1Archer Pharmaceuticals, Sarasota, FL, USA
2Roskamp Institute, Sarasota, FL, USA
Hendrix Suzanne
3Pentara Corporation, Salt Lake City, UT, USA
Sean Kennelly
4Trinity College Dublin, Dublin, Ireland.
5Department of Age Related Healthcare, Tallaght Hospital, Dublin
Brian Lawlor
4Trinity College Dublin, Dublin, Ireland.
Mullan Michael
1Archer Pharmaceuticals, Sarasota, FL, USA
2Roskamp Institute, Sarasota, FL, USA
Posted June 20, 2018.
Exploratory analyses suggest less cognitive decline on nilvadipine treatment in very mild Alzheimer’s disease subjects
Laila Abdullah, Fiona Crawford, Langlois Heather, Hendrix Suzanne, Sean Kennelly, Brian Lawlor, Mullan Michael
bioRxiv 345652; doi: https://doi.org/10.1101/345652
Subject Area
Subject Areas
- Biochemistry (11740)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17410)
- Clinical Trials (138)
- Developmental Biology (9420)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12239)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28070)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)